Clinical trial Recruiting at 1 site Interventional Ages 3 to 6

Toy Nebulizer vs Distraction Cards to Ease Fear During Nebulization

Official title: (Effect of Toy Nebulizer Versus Distraction Cards on Children's Fear and Parental Satisfaction During Nebulization Therapy: A Comparative Study

Run by University of Baghdad · NCT07417839 · Data updated 2026-11-12

This study tests whether a toy nebulizer or distraction cards can reduce fear in children aged 3-6 during nebulization and improve parent satisfaction.

Quick facts

Study typeInterventional
Ages3 Years to 6 Years
SexAll
Enrollment120 (estimated)
SponsorUniversity of Baghdad
Academic / other
Locations1 site (Baghdad, Mousl)
StatusRecruiting
StartedApril 8, 2026
Main results expectedJuly 1, 2026
Study endsAugust 1, 2026
Registry record updatedAugust 3, 2026
Trial IDNCT07417839 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 3-6 receiving their first nebulization, with at least one parent available to participate and communicate in Arabic or Kurdish.

Probably not a fit

Children with prior nebulization, cognitive or developmental disabilities, or families unable to complete questionnaires may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized controlled trial, children aged 3-6 undergoing initial nebulization for acute respiratory conditions are assigned to either a toy nebulizer or distraction cards during sessions. Fear is measured with the Child Fear Scale and parental satisfaction with a 5-point scale, across four weeks of three sessions each. The goal is to see which non-pharmacological approach more effectively lowers fear and improves adherence to therapy. Data will be analyzed with t-tests and ANOVA to determine statistical differences (p < 0.05).

Why it matters

Potential benefit: If successful, the approach could reduce distress during nebulization and improve parents' confidence and willingness to continue therapy.

How similar studies have gone: Prior non-pharmacological methods like distraction have shown benefits; this study tests whether a toy device provides additional improvement.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:Children aged 3-6 years receiving nebulization therapy for the first time due to acute respiratory conditions (e.g., asthma or bronchitis).

2\. Presence of at least one parent (preferably the mother) during the procedure who is capable of evaluation and communication in Arabic or Kurdish.

3\. Children who are alert and able to cooperate (absence of severe pain or any condition preventing basic communication).

4\. Voluntary written informed consent obtained from the parents and assent from the child (where applicable).

\-

Exclusion Criteria:Prior history of nebulization therapy (to ensure the fear response is not conditioned by past experiences).

2\. Children with cognitive, neurological, or developmental disabilities, or severe chronic illnesses (e.g., terminal cancer).

3\. Parental inability to complete fear or satisfaction questionnaires due to disability or illiteracy.

4\. Refusal to participate by the child or parent, or the presence of emergency conditions requiring immediate life-saving intervention.

\-

Where it's running

  • Hospital Ibn Al Atheer
    Baghdad, Mousl, Iraq
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.